Antimicrobial Agents, Viral Pathogens, and Epidemiology: Core Concepts in Microbiology

Controlling Microbial Growth in the Body: Antimicrobial Agents

Introduction to Antimicrobial Agents

Antimicrobial agents are chemicals used to treat diseases caused by microorganisms. These agents are a subset of chemotherapeutic drugs, which are chemicals that affect the physiology of an organism to combat disease. The development of antimicrobial agents revolutionized medicine, allowing for the effective treatment of bacterial, fungal, and some viral infections.

• Antibiotics: Naturally produced by microorganisms (e.g., fungi, bacteria) to inhibit or kill other microbes.

• Synthetics: Completely synthesized in the laboratory.

• Semisynthetics: Chemically modified derivatives of natural antibiotics.

• Key historical figures: Paul Ehrlich ("magic bullets" and chemotherapy), Alexander Fleming (discovery of penicillin), Gerhard Domagk (sulfanilamide).

Mechanisms of Antimicrobial Action

Antimicrobial drugs work by exploiting differences between microbial cells and host cells, a concept known as selective toxicity. The main mechanisms include:

• Inhibition of Cell Wall Synthesis: Drugs like penicillin and vancomycin interfere with peptidoglycan formation, weakening bacterial cell walls.

• Inhibition of Protein Synthesis: Target differences in ribosomal structure between prokaryotes and eukaryotes (e.g., tetracyclines, chloramphenicol).

• Disruption of Cytoplasmic Membranes: Drugs like amphotericin B bind to membrane sterols, forming pores and causing cell lysis.

• Inhibition of Metabolic Pathways: Sulfonamides act as structural analogs, blocking essential bacterial metabolic reactions.

• Inhibition of Nucleic Acid Synthesis: Quinolones and nucleotide analogs disrupt DNA/RNA synthesis.

• Prevention of Virus Attachment: Attachment antagonists block viral entry into host cells (still under development).

Spectrum of Action

The spectrum of action refers to the range of pathogens a drug affects:

• Narrow-spectrum drugs: Target specific types of pathogens (e.g., penicillin for Gram-positive bacteria).

• Broad-spectrum drugs: Affect a wide variety of organisms but may disrupt normal microbiota, leading to secondary infections.

Testing Antimicrobial Efficacy

Determining the effectiveness of antimicrobial agents is crucial for clinical use. Common tests include:

• Diffusion Susceptibility Test (Kirby-Bauer): Measures zones of inhibition around drug-impregnated discs on agar plates.

• Minimum Inhibitory Concentration (MIC) Test: Identifies the lowest concentration of drug that inhibits visible growth.

• Etest: Combines MIC and diffusion methods using a gradient strip.

• Minimum Bactericidal Concentration (MBC) Test: Determines the lowest concentration that kills the organism.

Routes of Administration

The method of drug delivery affects its concentration and efficacy at the site of infection:

• Topical: For surface infections.

• Oral: Convenient but may result in lower concentrations at the infection site.

• Intramuscular (IM): Faster absorption than oral.

• Intravenous (IV): Rapid and high drug levels in the blood.

Safety and Side Effects

Antimicrobial agents can cause adverse effects:

• Toxicity: Damage to organs or developing fetus.

• Allergies: Can trigger severe reactions, including anaphylactic shock.

• Disruption of Normal Microbiota: May lead to secondary infections (e.g., Candida albicans).

Resistance to Antimicrobial Drugs

Microbial resistance is a growing concern. Resistance can develop through genetic mutations or acquisition of resistance genes (e.g., R-plasmids). Mechanisms include:

• Enzyme production that destroys or inactivates the drug.

• Prevention of drug entry into the cell.

• Alteration of drug targets.

• Efflux pumps that expel the drug.

Retarding Resistance

• Use drugs at effective concentrations and for appropriate durations.

• Combine drugs for synergistic effects.

• Limit use to necessary cases.

• Develop new drugs and modify existing ones (second- and third-generation drugs).

Characterizing and Classifying Viruses, Viroids, and Prions

Introduction to Acellular Pathogens

Viruses, viroids, and prions are acellular infectious agents that rely on host cells for replication. They are responsible for a wide range of diseases in humans, animals, plants, and bacteria.

Characteristics of Viruses

• Acellular: Not composed of cells; obligate intracellular parasites.

• Structure: Consist of a nucleic acid core (DNA or RNA) surrounded by a protein coat (capsid). Some have an additional envelope derived from host membranes.

• Virion: The extracellular, infectious form of a virus.

Genetic Material of Viruses

• Can be DNA or RNA, single- or double-stranded.

• Genome size is typically much smaller than that of host cells.

Hosts and Specificity

• Viruses are often host-specific, infecting only certain cell types or species.

• Bacteriophages infect bacteria; plant viruses infect plants; animal viruses infect animals.

Sizes and Morphology

• Viruses are much smaller than bacteria and eukaryotic cells.

• Capsid shapes: helical, polyhedral, complex.

The Viral Envelope

• Enveloped viruses have a phospholipid membrane with embedded proteins (spikes).

• Envelope is acquired during viral release from the host cell.

Classification of Viruses

• Based on nucleic acid type, capsid shape, presence/absence of envelope, and size.

Viral Replication

Viruses replicate by hijacking host cell machinery. The lytic cycle includes:

1. Attachment

2. Entry

3. Synthesis

4. Assembly

5. Release

Lysogeny

Some bacteriophages can integrate their genome into the host DNA, becoming a prophage. This allows the virus to remain dormant until induced to enter the lytic cycle.

Replication of Animal Viruses

• Attachment via glycoprotein spikes.

• Entry by direct penetration, membrane fusion, or endocytosis.

• Genome replication depends on nucleic acid type (DNA or RNA, positive or negative sense).

• Assembly and release by budding (enveloped viruses) or lysis/exocytosis (naked viruses).

Latency and Cancer

• Latent viruses (proviruses) can remain dormant in host cells.

• Some viruses can activate oncogenes, leading to cancer (neoplasia, tumors, metastasis).

Viroids and Prions

• Viroids: Infectious RNA molecules, no capsid, infect plants.

• Prions: Infectious proteins causing spongiform encephalopathies (e.g., mad cow disease). Prions convert normal proteins into abnormal beta-pleated sheets.

Infection, Infectious Diseases, and Epidemiology

Symbiotic Relationships

Microbes interact with hosts in various symbiotic relationships:

• Mutualism: Both benefit (e.g., Escherichia coli in the colon).

• Commensalism: One benefits, the other is unaffected.

• Parasitism: One benefits at the expense of the other (most pathogens).

Normal Microbiota

• Resident microbiota: Permanent, stable populations on body surfaces.

• Transient microbiota: Temporary, outcompeted by resident flora.

• Normal flora can become opportunistic pathogens if the host is compromised or if they enter new body sites.

Reservoirs of Infection

• Animal reservoirs: Zoonoses are diseases transmitted from animals to humans.

• Human carriers: Infected individuals without symptoms can transmit disease.

• Nonliving reservoirs: Soil, water, and food.

Portals of Entry

• Skin (breaks, hair follicles, sweat glands)

• Mucous membranes (respiratory, gastrointestinal, urogenital tracts)

• Placenta

• Parenteral route (direct deposition into tissues)

Adhesion and Biofilms

• Pathogens use adhesion factors (ligands) to attach to host cells.

• Biofilms are communities of microbes attached to surfaces (e.g., dental plaque).

Manifestations and Causation of Disease

• Symptoms: Subjective effects (e.g., pain).

• Signs: Objective, measurable effects (e.g., fever).

• Syndrome: Group of signs and symptoms characteristic of a disease.

• Etiology: Study of disease causation; Koch's postulates are used to identify causative agents.

Virulence Factors

• Adhesion factors

• Extracellular enzymes: Hyaluronidase, collagenase, coagulase, kinases

• Toxins: Exotoxins (cytotoxins, neurotoxins, enterotoxins), endotoxins (Lipid A)

• Antiphagocytic factors: Capsules, M proteins, leukocidins

Stages of Infectious Disease

1. Incubation period

2. Prodromal period

3. Illness

4. Decline

5. Convalescence

Transmission of Infectious Diseases

• Contact transmission: Direct, indirect (fomites), droplet

• Vehicle transmission: Airborne, waterborne, foodborne

• Vector transmission: Biological (e.g., mosquitoes), mechanical (e.g., flies)

Classification and Epidemiology of Infectious Diseases

• Acute: Rapid onset, short duration

• Chronic: Slow onset, long duration

• Latent: Inactive for long periods

• Communicable: Spread from host to host

• Non-communicable: Not spread between hosts

Epidemiology

• Incidence: Number of new cases in a given time period

• Prevalence: Total number of cases in a given time period

• Endemic: Constantly present in a population

• Sporadic: Occurs occasionally

• Epidemic: Sudden increase in cases

• Pandemic: Epidemic on multiple continents

Nosocomial (Healthcare-Associated) Infections

• Exogenous: From the healthcare environment

• Endogenous: From the patient's own microbiota

• Iatrogenic: Resulting from medical procedures

• Superinfections: Due to disruption of normal microbiota

Control and Public Health

• Hand washing, sterile technique, and proper disposal of sharps are essential for infection control.

• Public health agencies monitor, report, and educate to prevent and control disease outbreaks.